Cancer Research Annual Meeting 2010  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rigas, B.
Right arrow Articles by Lipkin, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rigas, B.
Right arrow Articles by Lipkin, M.
[Cancer Research 61, 8381-8384, December 1, 2001]
© 2001 American Association for Cancer Research


Advances in Brief

Decreased Expression of DNA-dependent Protein Kinase, a DNA Repair Protein, during Human Colon Carcinogenesis

Basil Rigas1, Simona Borgo, Abdelmonem Elhosseiny, Vassilios Balatsos, Zisoula Manika, Hiromi Shinya, Naoto Kurihara, Mae Go and Martin Lipkin

American Health Foundation [B. R., S. B.] and New York Medical College [B. R., A. E.], Valhalla, New York 10595; Strang Cancer Prevention Center, New York, New York 10021 [S. B., H. S., N. K., M. L.]; G. Genimatas Hospital, Athens, Greece [V. B., Z. M.]; and Veterans Affairs Medical Center, Salt Lake City, Utah 84148 [M. G.]

DNA-dependent protein kinase (DNA-PK), consisting of a catalytic subunit (DNA-PKcs) and the Ku70 and Ku86 proteins, participates in the repair of DNA double-strand breaks (DSBs). We assessed its expression immunohistochemically in normal human colon tissue, colon adenomas, colon carcinomas, and normal tissue distant from carcinomas. Normal colonocytes expressed all DNA-PK proteins. Compared with the expression in normal tissue [176.62 ± 18.56 (the intensity of expression x the percentage of cells expressing this protein), mean + SE], the expression of Ku70 was significantly reduced in adenomas (36.62 ± 11.09; P < 0.001) and carcinomas (85.68 ± 15.76; P < 0.01), as was the expression of Ku86 [(113.10 ± 10.22 versus 41.66 ± 14.71 in adenomas (P < 0.01) or versus 85.68 ± 15.76 in carcinomas (P < 0.05)]. The expression of DNA-PKcs was not significantly changed. The marked underexpression of Ku70 and Ku86 starting at the adenoma stage may be crucial to the development of colon cancer.




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Idogawa, M. Masutani, M. Shitashige, K. Honda, T. Tokino, Y. Shinomura, K. Imai, S. Hirohashi, and T. Yamada
Ku70 and Poly(ADP-Ribose) Polymerase-1 Competitively Regulate {beta}-Catenin and T-Cell Factor-4-Mediated Gene Transactivation: Possible Linkage of DNA Damage Recognition and Wnt Signaling
Cancer Res., February 1, 2007; 67(3): 911 - 918.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
P Parrella, P Mazzarelli, E Signori, G Perrone, G F Marangi, C Rabitti, M Delfino, M Prencipe, A P Gallo, M Rinaldi, et al.
Expression and heterodimer-binding activity of Ku70 and Ku80 in human non-melanoma skin cancer
J. Clin. Pathol., November 1, 2006; 59(11): 1181 - 1185.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. D. Kennedy and A. D. D'Andrea
DNA Repair Pathways in Clinical Practice: Lessons From Pediatric Cancer Susceptibility Syndromes
J. Clin. Oncol., August 10, 2006; 24(23): 3799 - 3808.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. M. Sturgeon, Z. A. Knight, K. M. Shokat, and M. Roberge
Effect of combined DNA repair inhibition and G2 checkpoint inhibition on cell cycle progression after DNA damage.
Mol. Cancer Ther., April 1, 2006; 5(4): 885 - 892.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Grabsch, M. Dattani, L. Barker, N. Maughan, K. Maude, O. Hansen, H. E. Gabbert, P. Quirke, and W. Mueller
Expression of DNA Double-Strand Break Repair Proteins ATM and BRCA1 Predicts Survival in Colorectal Cancer
Clin. Cancer Res., March 1, 2006; 12(5): 1494 - 1500.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Dumon-Jones, P.-O. Frappart, W.-M. Tong, G. Sajithlal, W. Hulla, G. Schmid, Z. Herceg, M. Digweed, and Z.-Q. Wang
Nbn Heterozygosity Renders Mice Susceptible to Tumor Formation and Ionizing Radiation-Induced Tumorigenesis
Cancer Res., November 1, 2003; 63(21): 7263 - 7269.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
S. Ueda, T. Mineta, K. Suzuyama, M. Furuta, T. Shiraishi, and K. Tabuchi
Biologic characterization of a secondary glioblastoma with extracranial progression and systemic metastasis
Neuro-oncol, January 1, 2003; 5(1): 14 - 18.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.